Show simple item record

dc.contributor.authorEvans, Mark
dc.contributor.authorSathyanarayanan, Abilash
dc.contributor.authorCrabtree, Thomas
dc.contributor.authorChoudhary, Pratik
dc.contributor.authorElliott, Jackie
dc.contributor.authorLumb, Alistair
dc.contributor.authorWilmot, Emma
dc.date.accessioned2022-02-09T00:30:59Z
dc.date.available2022-02-09T00:30:59Z
dc.identifier.issn0168-8227
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/333764
dc.description.abstractThis review considers the impact of the SARS-COV-2 pandemic on access to evidence-based interventions for those living with Type 1 diabetes in the UK and discusses the novel solutions which have been considered and actioned to ensure ongoing access to high quality care. Methods: We performed a focussed review of the published literature, and the guidelines for changes that have been effected during the pandemic. We also drew from expert recommendations and information about local practice changes for areas where formal data have not been published. Results: Evidence based interventions which support the achievement of improved glucose levels and/or reduction in hypoglycaemia include group structured education to support self-management, insulin pump therapy and continuous glucose monitoring. However, the SARS-CoV-2 pandemic had impacted the ability of diabetes services to deliver these interventions, transforming services into a virtual world. Multiple adaptations have been put in place – transition to online delivery of education and care, and increased usage of diabetes technology in management. Conclusions: Although various adaptations have been made during the pandemic that have positively influenced uptake of services, there are many areas of delivery that need immediate improvement in the UK. We recommend a proactive approach in recognising the digital divide and inequity in distribution of these changes and we recommend introducing measures to reduce them.
dc.description.sponsorshipClinical Academic reserve
dc.publisherElsevier
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleDelivering evidence-based interventions for Type 1 diabetes in the virtual world – a review of current UK practice.
dc.typeArticle
dc.publisher.departmentDepartment of Medicine
dc.date.updated2022-02-08T10:15:18Z
prism.publicationNameDiabetes Research and Clinical Practice
dc.identifier.doi10.17863/CAM.81181
dcterms.dateAccepted2022-02-08
rioxxterms.versionAM
dc.contributor.orcidEvans, Mark [0000-0001-8122-8987]
rioxxterms.typeJournal Article/Review
cam.orpheus.counter10*
cam.depositDate2022-02-08
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement
rioxxterms.freetoread.startdate2025-02-08


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International